- Conditions
- Neonatal Abstinence Syndrome, Vagal Tone
- Interventions
- Vagal tone assessment
- Device
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- Up to 1 Day
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Spark Biomedical Roo Transcutaneous Auricular Neurostimulation (tAN) System
- Device
- Lead sponsor
- Spark Biomedical, Inc.
- Industry
- Eligibility
- 33 Weeks to 1 Year
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020
- U.S. locations
- 1
- States / cities
- Charleston, South Carolina
- Conditions
- Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome
- Interventions
- Sparrow Fledging Therapy System, Sham Sparrow Fledging Therapy System
- Device
- Lead sponsor
- Spark Biomedical, Inc.
- Industry
- Eligibility
- 33 Weeks to 1 Year
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 3
- States / cities
- Charleston, South Carolina • Dallas, Texas • San Antonio, Texas
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Stochastic Vibrotactile Stimulation (SVS), Control
- Device · Other
- Lead sponsor
- University of Massachusetts, Worcester
- Other
- Eligibility
- 1 Day to 1 Year
- Enrollment
- 46 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2019
- U.S. locations
- 1
- States / cities
- Worcester, Massachusetts
- Conditions
- Steatohepatitis, Nonalcoholic
- Interventions
- ION224, Placebo
- Drug · Other
- Lead sponsor
- Ionis Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 160 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 50
- States / cities
- Chandler, Arizona • Glendale, Arizona • Tucson, Arizona + 43 more
- Conditions
- NAS
- Interventions
- Song of Kin, Gato box, Ocean disc, Contingent singing, Tonal Vocal holding, Muted shaker
- Behavioral · Other
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Other
- Eligibility
- 28 Weeks and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2026
- U.S. locations
- 6
- States / cities
- New Orleans, Louisiana • Hackensack, New Jersey • New Hyde Park, New York + 3 more
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Acupuncture
- Other
- Lead sponsor
- University of South Florida
- Other
- Eligibility
- 1 Day to 3 Months
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- buprenorphine, Oral morphine solution
- Drug
- Lead sponsor
- Thomas Jefferson University
- Other
- Eligibility
- Not listed
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2010
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Clonidine, Phenobarbital
- Drug
- Lead sponsor
- Baystate Medical Center
- Other
- Eligibility
- Up to 15 Days
- Enrollment
- 68 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 1
- States / cities
- Springfield, Massachusetts
- Conditions
- Neonatal Abstinence Syndrome, Neonatal Withdrawal Syndrome
- Interventions
- Buprenorphine, Morphine Sulfate
- Drug
- Lead sponsor
- Pediatrix
- Other
- Eligibility
- Up to 1 Year
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2017
- U.S. locations
- 1
- States / cities
- Phoenix, Arizona
- Conditions
- Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
- Interventions
- Cotadutide, Placebo
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 54 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 29
- States / cities
- Tucson, Arizona • Canoga Park, California • Gilroy, California + 23 more
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Stochastic Vibrotactile Stimulation (SVS)
- Device
- Lead sponsor
- Elisabeth B Salisbury
- Other
- Eligibility
- 1 Hour to 18 Months
- Enrollment
- 208 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2021
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- High Calorie Infant formula, Standard Calorie Infant Formula
- Other
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 1 Day to 3 Days
- Enrollment
- 85 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Clonidine HCL
- Drug
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- NIH
- Eligibility
- Up to 14 Days
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2005
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Non-Alcoholic Steatohepatitis
- Interventions
- SHP626, Placebo
- Drug
- Lead sponsor
- Mirum Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 197 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 49
- States / cities
- Coronado, California • Fresno, California • Los Angeles, California + 42 more
- Conditions
- Maternal Opioid Use Disorder, Opioid Exposed Infant
- Interventions
- fetal monitoring, Buprenorphine Naloxone
- Device · Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years to 44 Years · Female only
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2023
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Telemedicine, Group Care
- Behavioral
- Lead sponsor
- Wendy F Hansen
- Other
- Eligibility
- 18 Years to 55 Years · Female only
- Enrollment
- 269 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 11
- States / cities
- Ashland, Kentucky • Bowling Green, Kentucky • Corbin, Kentucky + 7 more
- Conditions
- Non Alcoholic Fatty Liver Disease
- Interventions
- Weight loss, Exercise
- Behavioral
- Lead sponsor
- University of Missouri-Columbia
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2015
- U.S. locations
- 1
- States / cities
- Columbia, Missouri
- Conditions
- Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal
- Interventions
- Neonatal Morphine Solution, Methadone, Phenobarbital
- Drug
- Lead sponsor
- Tufts Medical Center
- Other
- Eligibility
- Not listed
- Enrollment
- 117 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2018
- U.S. locations
- 8
- States / cities
- Jacksonville, Florida • Portland, Maine • Boston, Massachusetts + 4 more
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Clonidine, Placebo
- Drug
- Lead sponsor
- Hennepin County Medical Center, Minneapolis
- Other
- Eligibility
- 36 Weeks to 45 Weeks
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 1
- States / cities
- Minneapolis, Minnesota
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Human Milk, Standard of Care
- Other
- Lead sponsor
- The University of Texas Health Science Center at San Antonio
- Other
- Eligibility
- Up to 48 Hours
- Enrollment
- 19 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 2
- States / cities
- San Antonio, Texas
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Weighted Blanket, Non-Weighted Blanket
- Other
- Lead sponsor
- TriHealth Inc.
- Other
- Eligibility
- 37 Weeks and older
- Enrollment
- 16 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- Cincinnati, Ohio
- Conditions
- Neonatal Abstinence Syndrome, Opioid-use Disorder
- Interventions
- Mobile-based NAS Caregiving Tool
- Behavioral
- Lead sponsor
- Washington State University
- Other
- Eligibility
- 18 Years to 99 Years · Female only
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Spokane, Washington
- Conditions
- Neonatal Abstinence Syndrome
- Interventions
- Phenobarbital, Clonidine
- Drug
- Lead sponsor
- University of Tennessee Medical Center
- Other
- Eligibility
- 35 Weeks and older
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Knoxville, Tennessee